Efforts to improve the quality of care—and ensure that fair and meaningful quality measures are part of this endeavor—bring key statistical concepts to the forefront. Because of the Medicare Access and CHIP Reauthorization Act (MACRA), ophthalmologist reimbursements will be more associated with quality and improvement (eg, Merit-based Incentive Payment System [MIPS]) and eligible alternative payment models (APMs). Indeed, insurance companies are already selecting providers that have documented higher quality and lower cost for participation in insurance company provider panels. Thus, clinical research and statistics are useful not only for understanding the scientific literature and providing care for patients, but also for influencing the practices and livelihoods of providers, including ophthalmologists.
Sloan FA, Brown DS, Carlisle ES, Picone GA, Lee PP. Monitoring visual status: why patients do or do not comply with practice guidelines. Health Serv Res. 2004;39(5):1429–1448.
Excerpted from BCSC 2020-2021 series: Section 1 - Update on General Medicine. For more information and to purchase the entire series, please visit https://www.aao.org/bcsc.